查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1765398

全球實驗室晶片市場

Lab-on-a-Chip
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，美國實驗室晶片市場規模將達到 142 億美元

全球實驗室晶片市場規模預計在2024年為83億美元，預計到2030年將達到142億美元，2024年至2030年的複合年成長率為9.4%。作為報告分析的細分市場之一，儀器市場預計將以10.0%的複合年成長率成長，並在分析期結束時達到80億美元。試劑和耗材市場在分析期間的複合年成長率預計為9.3%。

美國市場規模預估為 23 億美元，中國市場預估複合年增率為 8.8%

美國實驗室晶片市場規模預計在2024年達到23億美元。作為世界第二大經濟體，中國預計在2030年達到22億美元的市場規模，在2024年至2030年的分析期間內，複合年成長率為8.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為8.8%和7.5%。在歐洲，預計德國的複合年成長率約為7.5%。

全球實驗室晶片市場—主要趨勢與促進因素摘要

實驗室晶片將如何徹底改變診斷？

實驗室晶片(LOC) 技術正在革新診斷技術，它使複雜的檢測流程能夠在緊湊的微流體晶片上進行。這些設備將多種檢測功能（包括樣品製備、檢測和數據分析）整合到單一晶片上，從而提供快速、準確且經濟高效的診斷解決方案。 LOC 系統尤其適用於照護現場(POC)，例如急診和遠距醫療機構，在這些情況下，快速獲得結果對於及時決策至關重要。能夠快速檢測生物標記、病原體和基因突變的實驗室晶片設備正在推動醫療診斷向更有效率、更便捷的方向轉變，這些診斷可以在需要時進行，而無需在中心實驗室進行。

為什麼個人化醫療和基因組學推動了對實驗室晶片的需求？

個人化醫療和基因組學的興起極大地推動了對實驗室晶片設備的需求，這些設備是進行精準、針對患者的診斷的理想選擇。個人化醫療著重於根據個別基因圖譜制定個人化治療方案，這需要快速可靠的基因資訊分析。實驗室晶片技術使PCR和DNA測序等複雜的基因組分析實現微型化和自動化，與傳統方法相比，減少了所需的時間和資源。隨著個人化醫療在腫瘤學和罕見疾病管理等領域的日益普及，晶片實驗室設備正成為提供針對性醫療保健解決方案的重要工具，使在患者層面進行高階診斷變得更加可行。

小型化和便攜性如何影響研究和診斷？

微型化和便攜性是實驗室晶片技術的核心優勢，使其能夠廣泛應用於研究實驗室、現場診斷和資源有限的環境中。晶片實驗室設備體積小巧，便於攜帶各種先進的檢測功能，從分子生物學實驗到病原體檢測，從而方便在缺乏完整實驗室基礎設施的地區進行診斷。這些設備在偏遠和資源匱乏的環境中尤其有益，因為它們可以用最少的樣品和試劑量進行分析，從而降低成本並減少廢棄物。此外，微流體系統和感測器與數位連接的整合實現了即時數據傳輸，從而實現了遠端監控和雲端基礎的數據分析，從而增強診斷和研究洞察力。

推動實驗室晶片市場成長的因素是什麼？

實驗室晶片市場的成長受到多種因素的推動，包括快速診斷的需求、個人化醫療的進步以及對可攜式和微型實驗室系統日益成長的需求。醫療保健領域，尤其是在照護現場，對快速且準確的診斷的需求正在推動晶片實驗室技術的普及。個人化醫療的轉變需要精準的基因和分子分析，這也加速了晶片實驗室技術的普及，尤其是在腫瘤學和基因檢測等領域。此外，便攜性和極低的資源需求使其成為偏遠地區和資源受限環境的理想選擇，從而擴大了其市場覆蓋範圍。總而言之，這些因素支持實驗室晶片市場的擴張，以高效、精準地滿足現代醫療保健和研究需求。

部分

應用（基因組學和蛋白​​質組學、診斷學、藥物發現、其他應用）、細分市場（儀器、試劑和耗材、軟體和服務）

受訪公司範例

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • IDEX Corporation
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP16526

Global Lab-on-a-Chip Market to Reach US$14.2 Billion by 2030

The global market for Lab-on-a-Chip estimated at US$8.3 Billion in the year 2024, is expected to reach US$14.2 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$8.0 Billion by the end of the analysis period. Growth in the Reagents & Consumables segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 8.8% CAGR

The Lab-on-a-Chip market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.8% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Lab-on-a-Chip Market - Key Trends & Drivers Summarized

How Is Lab-on-a-Chip Revolutionizing Diagnostics?

Lab-on-a-chip (LOC) technology is transforming diagnostics by enabling complex laboratory processes to be performed on a compact, microfluidic chip. These devices integrate multiple laboratory functions, such as sample preparation, detection, and data analysis, onto a single chip, offering fast, accurate, and cost-effective diagnostic solutions. LOC systems are particularly valuable in point-of-care (POC) diagnostics, where rapid results are essential for timely decision-making, such as in emergency rooms or remote healthcare settings. With the ability to detect biomarkers, pathogens, and genetic mutations quickly, lab-on-a-chip devices are driving a shift toward more efficient, accessible healthcare diagnostics that can be administered at the point of need rather than in centralized laboratories.

Why Are Personalized Medicine and Genomics Driving Demand for Lab-on-a-Chip?

The rise of personalized medicine and genomics is significantly boosting the demand for lab-on-a-chip devices, which are ideal for precise, patient-specific diagnostics. Personalized medicine focuses on tailoring treatments based on individual genetic profiles, requiring rapid and reliable analysis of genetic information. Lab-on-a-chip technology allows for the miniaturization and automation of complex genomic analyses, such as PCR and DNA sequencing, reducing time and resource requirements compared to traditional methods. As personalized medicine gains traction in fields like oncology and rare disease management, LOC devices are becoming essential tools for delivering targeted healthcare solutions, making advanced diagnostics more feasible at the patient level.

How Is Miniaturization and Portability Impacting Research and Diagnostics?

Miniaturization and portability are central advantages of lab-on-a-chip technology, enabling its widespread adoption in research labs, field diagnostics, and resource-limited settings. The compact size of LOC devices allows for the portability of sophisticated testing capabilities, from molecular biology experiments to pathogen detection, facilitating diagnostics in locations without full laboratory infrastructure. These devices can perform analyses with minimal sample and reagent volumes, reducing costs and waste, which is particularly beneficial in remote and low-resource settings. Additionally, the integration of microfluidic systems and sensors with digital connectivity allows real-time data transfer, enabling remote monitoring and cloud-based data analysis for enhanced diagnostics and research insights.

What Drives the Growth of the Lab-on-a-Chip Market?

The growth in the lab-on-a-chip market is driven by several factors, including the demand for rapid diagnostics, advancements in personalized medicine, and the increasing need for portable, miniaturized lab systems. The need for fast and accurate diagnostics in healthcare, especially in point-of-care and emergency settings, is propelling the adoption of LOC technology. The shift toward personalized medicine, which requires precise genetic and molecular analysis, is also accelerating LOC usage, especially in fields like oncology and genetic testing. Furthermore, the advantages of portability and minimal resource requirements make LOC systems ideal for remote and resource-limited settings, expanding their market reach. These factors collectively support the lab-on-a-chip market’s expansion as it addresses modern healthcare and research needs with efficiency and precision.

SCOPE OF STUDY:

The report analyzes the Lab-on-a-Chip market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Genomics & Proteomics, Diagnostics, Drug Discovery, Other Applications); Segment (Instruments, Reagents & Consumables, Software & Services)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 16 Featured) -

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • IDEX Corporation
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Lab-on-a-Chip - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Miniaturized Diagnostics and Point-of-Care Testing
    • Growth in Personalized Medicine Driving Demand for Lab-on-a-Chip Solutions
    • Advancements in Microfluidics Technology Enhancing Chip Capabilities
    • Expansion of Applications in Genomics and Proteomics Research
    • Rising Use of Lab-on-a-Chip Devices in Infectious Disease Diagnosis
    • Increased Adoption in Drug Discovery and Development Processes
    • Growing Demand for Cost-Effective and Rapid Diagnostic Solutions
    • Development of Multi-Analyte Detection Chips for Comprehensive Testing
    • Higher Investment in Lab-on-a-Chip R&D by Pharmaceutical Companies
    • Growth of Wearable and Implantable Lab-on-a-Chip Devices for Monitoring
    • Expansion of Lab-on-a-Chip in Food Safety and Environmental Testing
    • Integration of AI and Big Data in Lab-on-a-Chip for Enhanced Analytics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Lab-on-a-Chip Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Genomics & Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Genomics & Proteomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • CHINA
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: China 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: Europe 6-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: France 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Italy 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: UK 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of World 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of World 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030

IV. COMPETITION